EGFR and central nervous system cancer: Taken together, these results suggest that IFI30‐mediated EGFR/AKT/GSK3β/β‐catenin signaling not only promotes the EMT‐like phenotype by up‐regulating the expression of Slug, but also subsequently enhanced invasion and chemoresistance of glioma cells (Figure 6I).